Molecular Designs simplifies HPV research with new multiplex PCR panel
Developed by a physician-led team, the panel arrives pre-plated in a 96-well format and features a modular, breakaway design to reduce waste and streamline lab workflows
27 Nov 2025
Molecular Designs, a developer and manufacturer of molecular infectious-disease assays, has launched its Human Papillomavirus (HPV) Simplicity Panel™, a next-generation multiplex PCR-based Research Use Only (RUO) panel designed to identify 14 high-risk HPV types.
The HPV Simplicity Panel supports the research of high-risk HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, and delivers same-day results with high analytical accuracy and reproducibility.
Built for speed and ease of use, the panel comes pre-plated in a 96-well format and requires no master-mix preparation. Its modular, breakaway design allows labs to use only the tests they need, reducing waste and improving resource management.
More than 42 million Americans are currently living with disease-causing types of HPV, with approximately 13 million new infections occurring each year. Most infections clear naturally, but persistent HPV can lead to cancers of the cervix, genitals, anus, or throat. The HPV Simplicity Panel gives research laboratories a streamlined tool to study high-risk HPV prevalence and its role in disease development.
“HPV remains a significant public health concern, and we’re proud to help lab leaders play an active role in clinical research,” said Michael Clark, CEO of Molecular Designs. “This panel was designed to help research labs generate reliable data faster and more efficiently while maintaining the high-quality standards that are central to all of our Simplicity products.”